Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Butler

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Journal of Drugs in Dermatology : JDD|December 4, 2024
International Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual MeetingArianna J Zhang, Gretchen Ball, Melissa P Zundell, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 16, 2024
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trialMay Ee Png, Victoria Harris, Jenna Grabey, et al.
The Journal of Clinical Investigation|February 28, 2023
Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilegeYinghua Ma, David Sannino, Jennifer R Linden, et al.
Cell Reports|November 26, 2020
Circulating miRNA Spaceflight Signature Reveals Targets for Countermeasure DevelopmentSherina Malkani, Christopher R Chin, Egle Cekanaviciute, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Geospatially-resolved public-health surveillance via wastewater sequencingBraden T Tierney, Jonathan Foox, Krista A Ryon, et al.
The Journal of Clinical Investigation|February 11, 2014
Memory regulatory T cells reside in human skinRobert Sanchez Rodriguez, Mariela L Pauli, Isaac M Neuhaus, et al.
The Lancet. Infectious Diseases|September 12, 2024
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trialVictoria Harris, Jane Holmes, Oghenekome Gbinigie-Thompson, et al.
Nature Communications|September 27, 2024
Towards geospatially-resolved public-health surveillance via wastewater sequencingBraden T Tierney, Jonathan Foox, Krista A Ryon, et al.
Journal of the American Academy of Dermatology|October 31, 2025
International multicenter case series of gestational dupilumab exposure in the treatment of atopic dermatitis: Maternal complications and fetal outcomesAjay S Dulai, Emi M Murase, Gianluca Avallone, et al.
Genome Biology|December 7, 2021
The SEQC2 epigenomics quality control (EpiQC) studyJonathan Foox, Jessica Nordlund, Claudia Lalancette, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Journal of Drugs in Dermatology : JDD|December 4, 2024
International Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual MeetingArianna J Zhang, Gretchen Ball, Melissa P Zundell, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 16, 2024
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trialMay Ee Png, Victoria Harris, Jenna Grabey, et al.
The Journal of Clinical Investigation|February 28, 2023
Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilegeYinghua Ma, David Sannino, Jennifer R Linden, et al.
Cell Reports|November 26, 2020
Circulating miRNA Spaceflight Signature Reveals Targets for Countermeasure DevelopmentSherina Malkani, Christopher R Chin, Egle Cekanaviciute, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Geospatially-resolved public-health surveillance via wastewater sequencingBraden T Tierney, Jonathan Foox, Krista A Ryon, et al.
The Journal of Clinical Investigation|February 11, 2014
Memory regulatory T cells reside in human skinRobert Sanchez Rodriguez, Mariela L Pauli, Isaac M Neuhaus, et al.
The Lancet. Infectious Diseases|September 12, 2024
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trialVictoria Harris, Jane Holmes, Oghenekome Gbinigie-Thompson, et al.
Nature Communications|September 27, 2024
Towards geospatially-resolved public-health surveillance via wastewater sequencingBraden T Tierney, Jonathan Foox, Krista A Ryon, et al.
Journal of the American Academy of Dermatology|October 31, 2025
International multicenter case series of gestational dupilumab exposure in the treatment of atopic dermatitis: Maternal complications and fetal outcomesAjay S Dulai, Emi M Murase, Gianluca Avallone, et al.
Genome Biology|December 7, 2021
The SEQC2 epigenomics quality control (EpiQC) studyJonathan Foox, Jessica Nordlund, Claudia Lalancette, et al.
Pageof 9